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Bovine serum albumin (BSA) was used for generation of nanoparticles in a drug delivery system. The 
size of the fabricated nano-particles was measure by laser light scanning. Several process parameters 
were examined to achieve a suitable size of nanoparticle such as pH, temperature, BSA concentration, 
agitation speed, glutaraldehyde concentration, organic solvent adding rate and the ratio of 
BSA/organic solvent. The smallest size of nanoparticles achieved, was 101 nm and the largest size was 
503 nm. The most effective parameters for the fabrication of the nanoparticles were the agitation speed 
and the media temperature. The minimum size of nanoparticles at the desired incubator of 4°C and 
constant agitation rate of 300 - 400 rpm was obtained. The impact of protein concentration and 
additional rate of organic solvent (i.e. ethanol) upon the particle size was investigated. The protein 
concentration of 5-40 mg.ml-1 was resulted; the main effect on the particle size and minimum mean size 
diameter gained was 30 mg.ml-1 protein concentration. The nanoparticle sample was purified with 
50,000 g centrifuge then followed by dialysis, micro and ultrafiltration and then analyzed by SEM, PCS 
as well as SDS gel electrophoresis.  
 






In the past two decades, great interests were developed 
for the fabrication of nanoparticles, as drug delivery 
vehicles (Zhang et al., 2000). The nanoparticles must be 
manufactured in advanced stages of purity, with material 
definition and sophisticated formulation to rival those 
demanded by the pharmaceutical macromolecules 
(Zhang et al., 2000; Jahanshahi et al., 2004). Nano-
particle sizes are defined from 10 to 1000 nm. When the 
drug is encapsulated by the nanoparticles, the product 
are called nanocapsules, if the medicine is uniformly 
coated on the exterior of the nanoparticle then is called 
nanosphere. The carrier itself should be non-toxic and 
able to be degraded in vivo so that it does not 
accumulate indefinitely in tissues. BSA is a suitable 
carrier for drug therefore the nanoparticle generated from 
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shahi et al., 2005). 
Nanoparticles are colloids, generally composed of 
sophisticated biological structures. There are one or more 
types of proteins, lipids and/or nucleic acids (Langer et al., 
2003). Colloidal drug delivery system such as 
microspheres, liposomes and emulsions are used as 
intravenously injected carriers for drug delivery to specific 
organs or targeted sites within human body (Davis and 
Illum, 1986). In colloidal system, the size of particle is 
very important in distribution of drug in human body. 
Generally, the large particle is easily removed by liver 
and spleen. The stability of small particle is higher than 
the large particle in drug delivery devices. Reducing the 
size of colloidal particle carriers in the range of 100 to 
200 nm, enhance the stability of the carrier nanoparticles 
and creates the chance of escaping from the vascular 
system via cavities in the lining of blood vessel (Muller et 
al., 1996).  
Liposomes are in nanoscale size range, self-assemble 
based on hydrophilic and hydrophobic properties and 
used for encapsulation of drug.  Liposomes are quite pot- 
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ential drug carriers instead of conventional use of drug 
dosage since it may protect the drug from degradation; 
also reduce the toxicity of the drug and side effects 
(Muller et al., 1996; Soppimath et al., 2001). It was 
reported that liposome loaded with doxorubicin with 
particle size of 100 nm was commercially used as 
anticancer drug (Soppimath et al., 2001).  However there 
are disadvantages in use of liposome which has low 
encapsulation efficiency, rapid leakage of water-soluble 
drug in presence of blood component and poor storage 
stability (Soppimath et al., 2001). 
Synthetic protein nanostructure act as surrogate 
mimics such as viruses and plasmid for drug delivery 
system. The benefits of protein nanoparticles are: non-
toxicity, stability for long duration, non-antigen also posse 
biodegradability (Muller et al., 1996; Weber et al., 2000). 
In fact protein is biopolymer, which is commonly used for 
preparation of nanostructured molecules for drug delivery 
(lazko et al., 2004). Figure 1 shows the schematic 
diagram of nanocapsulated and nanosphere particles 
loaded with drug. Simple and complex coacervation 
techniques for separation of proteins in two liquid phases 
in colloidal systems were used (Soppimath et al., 2001; 
Kruif et al., 2004; Mohanty and Bohidar, 2003). The 
phase with more concentrated in colloidal component is 
the coacervate and the other phase is the equilibrium 
solution. Association of two polymers in aqueous phase 
occurs with electrostatic attention (Arnedo et al., 2004).  
The purpose of this research paper was to fabricate 
nanoparticles in the unique range which is suitable for the 
drug delivery system. The effected of manufacturing 
conditions such as pH, temperature, BSA concentration, 
agitation speed, organic solvent adding rate etc. upon the 
fabrication of such nanoparticle is strongly investigated. 




BSA (fraction V, purity 98%), Tween-20, ethanolamine and 
glutaraldehyde (25% solution), were commercially supplied by 
Sigma Aldrich. Analytical grade and high purity of sodium azide and 
all other chemicals were supplied from Merck (Germany).  
 
 
Preparation of BSA noanoparticles 
 
Simple coacervation technique was implemented for preparation of 
BSA nanoparticles (lazko et al., 2004). Anhydrous ethyl alcohol was 
added to 150 ml BSA (5 mg/l in 10 mM Tris/HCl contained 0.02% 
sodium azide, pH 7.5) till the solution became turbid then 150 l of 
25% glutaraldehyde was added for cross linking. The reaction was 
continued at room temperature (24°C). Ethanolamine was added to 
block the non-reacted aldehyde functional group. Also Tween-20 
was added at a final concentration of 0.01% (v/v) to stabilize the 
preparation. Large aggregates were eliminated by centrifuge 
(50,000 g, 30 min, 4°C). The supernatant was dialyzed and 
subsequently micro and ultrafiltrated through a 0.2 m acetate 
membrane and polyvinylchloride copolymer membrane with cut off 
300 kDa, respectively. The concentration of BSA determined with 
coomassie blue reagent (Bradford, 1976). The size distribution and 
shape of BSA nanoparticles were determined by scanning 
electronic microscope (SEM) (Zhang et al., 2000).  
 
 
Determination of nanoparticle size and distribution 
 
The size distribution of the prepared BSA nanoparticle was 
analysed by photon correlation spectroscopy (PCS). PCS is 
industrially preferred method of sub-micron particle size analysis. 
The sample analyzed in the PCS device should consist of well 
dispersed particles in liquid medium. In such conditions the 
particles are in constant random motion, referred to as Brownian 
motion and PCS measures the speed of this motion by passing a 
laser. PCS  determines  the average particle size and Polydispersity  
  






Figure 2. Scanning electronic microscopy of the outer surface of the BSA nanoparticles. a: Outer 
surface of the particle with magnification of 30000. b: Outer surface of the particle with 




Index (PI) which is a range of measurement of the particle sizes 
within measured samples. The accurate measurement of particle 
size must be blow 0.7 (70%). 
 
 
Scanning electronic microscopic (SEM) 
 
For electronic microscopic scanning micrographs, samples were 
taken from nanoparticles that were experimentally obtained. The 
samples were dipped into liquid nitrogen for 10 min, then freeze 
dried for 7 h in the Freeze Drier, EMITECH, model IK750, 
Cambridge, UK. The sample was fixed on the aluminium stub and 
coated with gold palladium by Polaron machine model SD515, 
EMITECH, Cambridge, UK, at 20 nm coating thickness. Finally the 
sample was examined under SEM using Stereoscan model S360 
brand SEM-Leica Cambridge, Cambridge, UK. 
 
 
Determination of particle purity  
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) was formed to analyse and compare the protein 
composition profiles of specific samples. The pore size of poly 
acrylamide is limited; therefore proteins higher than 800 kDa can 
not permeate into the gel (Voet and Voet, 2004). An acrylamide 
concentration of 10% has been selected to enable optimal 
resolution for the soluble proteins (Samebrook et al., 1998). This 
property can be used to separate nanoparticles from monomeric 
proteins. Since protein monomers are separated in the gel, the 
nanoparticle stay on the stacking gel. The monomers are collected 
on top of the resolution gel (based on monomer size). 
 
 
RESULTS AND DISCUSSION 
 
Physical characterization of nanoparticles 
 
A range of protein (BSA) nanoparticle having broadly 
similar particle sizes and anionic characters to other 
nanoparticle such as adenovirus and plasmid DNA were 
fabricated based on simple coacervation. Average parti-
cle size in base of size distribution was calculated by 
PCS. 
In addition, the morphology and size distribution of the 
prepared nanoparticles from BSA were examined with 
scanning electronic microscope. Figures 2a and b show 
the particle size with magnification of 30 000 and 60 000, 
respectively. The shape of the nanoparticles demonstra-
ted in SEM is spherical. The sizes of fabricated nanopar-





The gel electrophoresis SDS-PAGE was formed to 
analyze and compare the purity of the prepared nanopar-
ticles with pure BSA. Figure 3 represents the gel electro-
phoresis of pure BSA and the nanoparticles prepared 
from BSA. The experimented concentrations of pure BSA 
and the nanoparticles from BSA were 10, 20 and 30 l. 
The protein bands are shown the nanoparticles were 




The effect of different parameters on nanoparticle 
size 
 
The impact of pH, temperature, BSA concentration, molar 
ratio of BSA to ethanol, agitation speed and the rate of 
ethanol addition on the nanoparticle size was studied. 
The effect of BSA concentration on nanoparticle size was 
conducted and shown in Figure 4. As the concentration of 
BSA increased, the particle size was decreased. The 
particle size of 204, 191, 163.6 and 145.7 nm were fabric-
cated with BSA concentration of 5, 10, 20 and 30 mg/ml, 
respectively. Beyond a certain BSA concentration (30 
mg/ml), the particle size was unaffected with concentra-
tion of BSA. 
Figure 5 illustrates the particle size may not be 
influenced with the change of pH since the concentration 







Figure 3. Gel electrophoresis of the BSA nanoparticles with 10, 20 
and 30 l. The different amount of samples (10, 20, 30 l) were 
analyzed by gel electrophoresis (SDS-PAGE).All samples were 






Figure 4. Effect of concentration of BSA on nanoparticle 
size. The influences of initial BSA concentration on BSA 
nanoparticle diameter have been investigated. The 
experiment were carried out at room temperature, by 200 
rpm agitation speed, ethanol adding rate of 1.5 ml.ml-1 in 
the solution with pH=7.5. The diameters of fabricated 
nanoparticles subsequently were measured by PCS. 
 
 
may slightly fluctuates therefore the particle size are 
defined in the range of 170 to 210 nm. 
Figure 6 shows a minimum size of particle (138 nm) 
was  obtained  at  agitation  speed  of 500 rpm. Generally, 




















Figure 5. Effect of pH of BSA on nanoparticle size. 
Dependence of the pH value on the diameter of BSA 
nanoparticle prepared in pure water and 10 mM Tris-HCl 























Figure 6. Effect of agitation rate on nanoparticle size. 




the size of particle is expected to reduce with increasing 
trend of agitation speed (Jahanshahi et al., 2003). The 
particle size was unaffected with agitation speed of 
higher than 500 rpm.  
The effect of glutaraldehyde, which was used for cross 
linking of the nanoparticles, on size of particle was 
investigated. There was no influential concentration to 
have any impact on particle size (Figure 7). A similar 
result was declared on fabrication of protein nanop-
arcticles using human serum albumin (HAS). Langer and 
his coworkers (2003) reported that glutaraldehyde con-
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Figure 7. Effect of glutaraldehyde concentration on nanoparticle 
size. Influence of the cross linking process with different amount 




















Figure 8. Effect of ethanol addition on nanoparticle size. 
Diameter of BSA nanoparticle fabricated in pure water at 
initial BSA concentration of 5 mg ml-1as a function of the 




However, the rate of addition of ethanol on particle 
size was also experimented. There was no influence of 
ethanol concentration reflected on particle size (Figure 8). 
Similar results with HAS nanoparticle have been reported 
before (Langer et al., 2003). It should be noted that 
application of ethanol accelerated phase transition of 
organic phase. 
Figure 9 shows the effect of temperature on nanopar 




















Figure 9. Effect of temperature on nanoparticle size 


















Figure 10. Effect of volumetric ratio of BSA/ethanol on 
nanoparticle size during the fabrication procedure based on 




is temperature. Decreasing temperature will also 
decrease on the particle size. The minimum size of 101.4 
nm was obtained at 4°C and the largest size of the 
particle obtained was 202 nm at highest temperature 
34°C. 
The effect of the ratio of BSA/ethanol was also 
investigated in this research (Figure 10), as the ratio 
increased the particle size was decreased. Weber et al. 
(2000) reported that the volumetric ratio of BSA/ethanol 
was very influential parameter for the fabrication of 
nanoparticles due to the fact that ethanol was able to dis-
solve BSA with high solvency power. In fact the obtained 
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The biological nanoparticle (BSA) as it has been 
assembled here, not only mimics the size and surface 
chemistry of nanoparticles such as viruses and plasmid, 
but also can be used as drug delivery vehicles in its own 
right. Low BSA concentration of 5 mg.ml-1 was used in a 
simple coacervation method for preparation of nanoparti-
cles. The nanoparticles size fabricated from BSA was 
influenced by several process variables including agita-
tion speed, temperature and BSA concentration. In pre-
determined conditions (protein concentration of 5 mg.ml-1) 
the particle was prepared at 4°C, pH 7.5 and agitation 
rate of 500 rpm. The coacervation procedure appears 
promising in studies of BSA nanoparticle manufacture 
where temperature has been shown to be highly influen-
tial upon the mean size of fabricated nanoparticle. The 
minimum size of particle fabricated was 101.4 nm at the 
lowest temperature 4°C. Optimization of this fabrication 
method for protein nanoparticles as drug delivery sys-





The authors would like to gratefully acknowledge financial 
and technical support of Mazandaran University and 





Arnedo A, S Espuelas, JM Irache (2004). Albumin nanoparticle as 
carriers for a phosphodiester oligonucleotide. Int. J. Pharm. 244: 59-
72.  
Bradford MM (1976). A rapid and sensitive method for quantitation of 
microgram quantities of protein utilising the principle of protein dye-
binding. Analytical Biochemistry, 72: 248-254.  
Davis SS, L Illum (1986). Colloidal delivery systems, opportunities and 
challenges. E.T. Linson and S.S. Davis (Ed.), Site-specific Drug 
Delivery: cell Biology, Medical and pharmaceutical Aspects. John 
Wiley & Sons, Chichester: 931-993.  
Jahanshahi M, AW Pacek, AW Nienow, A Lyddiatt (2003).  Fabrication 
by three-phase emulsification of pellicular adsorbent customized for 
liquid fluidized bed adsorption products. J. Chem. Technol. 
Biotechnol. 78: 1111-1120.  
Jahanshahi M, Z. Zhang and A.Lyddiatt (2005). Subtractive 
chromatography for purification and recovery of Nano-bioproducts. J.  
IEE Proc-Nanobiotechnol. 152(3): 121-126.  
Jahanshahi M, S Williams, A Lyddiatt, SA Shojaosadati (2004). 
Preparation and purification of synthetic protein nanoparticulates. J. 
IEE Proc-Nano-biotechnol. 151(5): 176-182.  
Kruif CG, F Weinbreck, R Vries (2004). Complex coacervation of protein 
and anionic polysaccharides. Current Opinion in Colloid and 














Langer K, S Balthasar, V Vogel, N Dinauer, HV Briesen, D Schubert 
(2003). Optimization of the preparation process for human serum 
albumin (HSA) nanoparticle.  Int. J. Pharm. 257: 169-180.  
Lazko J, Y Popineau, J Legrand (2004). “Soy glycine microcapsules by 
simple coacervation method”. Colloids and Surface B: Biointerfaces 
37: 1-8. 
Mohanty B, HB Bohidar (2003). Systematic of alcohol-induced simple 
coacervation in aqueous gelatin solutions”. Biomarcromolecules 4: 
1080-1086.  
 Muller B, H Leuenberger, T Kissel (1996). Albumin nanospheres as 
carriers for passive drug targeting: an optimized manufacturing 
technique. Pharmaceutical Research 13(1): 32-37.  
Samebrook J, EF Fritsch, T Maniatis (1998). Molecular cloning: A 
Laboratory Manual, Cold Spring Harbor Laboratory Press. 
Soppimath KS, TM Aminabhavi, AR Kulkarni, W Rudzinski (2001). 
Biodegradable polymeric nanoparticles as drug delivery devise. J. 
Controlled Release 70: 1-20.  
Voet D, JG Voet (2004). Biochemistry, 3rd Edition, John Wiley, New 
York. 
Weber C, C Coester, J Kreuter, K Langer (2000). Desolvation process 
and surface characterization of protein nanoparticles. Int. J. Pharm. 
194: 91-102.  
Zhang Z, S Burton, S Williams, E Thwaites, A Lyddiatt (2000). Desing 
and assembly of solid-phases for the effective recovery of 
nanoparticulate bioproducts in fluidized bed contactors.  
Bioseparation 00:1-20. 
 
 
 
 
 
 
 
 
 
 
 
 
